Previously we found that TAPP2 was predominantly expressed in a more clinically aggressive ZAP-70+ subset of chronic lymphocytic leukemia (CLL) B cells [17], [18], known to be highly migratory in nature [19]. The gene discussed is PLEKHA2; the disease is B-cell chronic lymphocytic leukemia.